Application Nr Approved Date Route Status External Links
NDA206927 None Intravenous None Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

1 Indications And Usage Bortezomib For Injection Is A Proteasome Inhibitor Indicated For: Treatment Of Adult Patients With Multiple Myeloma (1.1 ) Treatment Of Adult Patients With Mantle Cell Lymphoma Who Have Received At Least 1 Prior Therapy (1.2) 1.1 Multiple Myeloma Bortezomib For Injection Is Indicated For The Treatment Of Adult Patients With Multiple Myeloma. 1.2 Mantle Cell Lymphoma Bortezomib For Injection Is Indicated For The Treatment Of Adult Patients With Mantle Cell Lymphoma Who Have Received At Least 1 Prior Therapy.

All Formulated Excipients (0 Total)

None

Active Ingredients ( 1 Total)

Name Structure ZINC ID(s)
1. Bortezomib BORTEZOMIB ZINC169746649

Comments